BiotechTube
Home/enGene/Alexey Revenko
AR

Alexey Revenko

Chief Scientific Officer and Co-Founder

enGene

Therapeutic Areas

OncologyInflammatory DiseasesGenetic Disorders

enGene Pipeline

DrugIndicationPhase
EG-70BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in Situ (CIS)Phase 1/2

Leadership Team at enGene

JH
Jason Hanson
Chief Executive Officer
RG
Richard Gammans
Chief Development Officer
IM
Ian McGowan
Chief Medical Officer
PY
Peter Yee
Chief Financial Officer
View full enGene profile